Skip to search formSkip to main contentSkip to account menu

Myrbetriq

National Institutes of Health

Related topics

Related topics

2 relations
24 HR mirabegron 50 MG Extended Release Oral Tablet [Myrbetriq]

Broader (1)

mirabegron

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AB321. SPR-48 The effects of myrbetriq on detrusor overactivity associated with suprasacral spinal cord injury (SCI) in rats
Objective β3-adrenoceptor agonists (BARA) represent a novel mechanism of action for direct relaxation of urinary bladder smooth… 
2012
2012
Myrbetriq (Mirabegron): A beta-3 adrenergic agonist indicated for the treatment of overactive bladder
New molecular entity: FDA approved Mirabegron (Myrbetriq, Astellas Pharma US) for the treatment of OAB with symptoms of urge… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)